← Back to Search

Procedure

Active cTBS for Dyslexia

N/A
Recruiting
Research Sponsored by Georgia State University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Normal or corrected to normal vision
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up immediately following ctbs
Awards & highlights

Study Summary

This trial aims to use a technique called transcranial magnetic stimulation (TMS) to study how older youth learn spoken words. The study will focus on how inhibiting a specific part of the brain

Who is the study for?
This trial is for older youth with dyslexia. Participants should be able to undergo brain stimulation and are interested in how it might affect learning new spoken words. Specific eligibility details aren't provided, so generally healthy individuals who meet the age requirement for 'older youth' may apply.Check my eligibility
What is being tested?
The study tests if a type of brain stimulation called cTBS can influence learning, processing, and remembering made-up words that sound similar. Some participants will receive real cTBS while others get a sham (fake) treatment to compare results.See study design
What are the potential side effects?
While specific side effects are not listed, TMS can sometimes cause discomfort at the stimulation site, headache, lightheadedness or seizures in very rare cases.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
My vision is normal or corrected to normal with glasses or contacts.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~5-mins post stimulation; 24hrs post stimulation
This trial's timeline: 3 weeks for screening, Varies for treatment, and 5-mins post stimulation; 24hrs post stimulation for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Novel Word Learning Task
Pseudoword Discrimination Task
Secondary outcome measures
MRI Scan

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: Active cTBSExperimental Treatment1 Intervention
Active cTBS will be administered to the left supramarginal gyrus
Group II: Sham stimulationPlacebo Group1 Intervention
Sham stimulation will be administered to the left supramarginal gyrus

Find a Location

Who is running the clinical trial?

Georgia State UniversityLead Sponsor
58 Previous Clinical Trials
25,429 Total Patients Enrolled
2 Trials studying Dyslexia
478 Patients Enrolled for Dyslexia
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)NIH
1,976 Previous Clinical Trials
2,680,626 Total Patients Enrolled
10 Trials studying Dyslexia
6,054 Patients Enrolled for Dyslexia

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is there an age requirement excluding individuals under 30 years old from participating in this medical study?

"To participate in this research, individuals must be aged between 16 and 24 years. There are a total of 48 trials designated for those under 18 and an additional 13 for participants over the age of 65."

Answered by AI

How many individuals are currently enrolled as participants in this clinical study?

"Indeed, the information on clinicaltrials.gov highlights that this trial is actively seeking volunteers. The study was initially uploaded on January 1st, 2024 and last modified on April 25th of the same year. It aims to recruit a total of 40 participants at one designated site."

Answered by AI

Is it possible for patients to enroll in this ongoing clinical trial?

"Indeed, data from clinicaltrials.gov highlights the ongoing recruitment for this trial. Originally shared on January 1st, 2024, and most recently revised on April 25th, 2024. The investigation aims to enroll 40 participants at a single site."

Answered by AI
~22 spots leftby Oct 2024